Microparticles from preeclamptic women induce vascular hyporeactivity in vessels from pregnant mice through an overproduction of NO

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 293, Issue 1, 2007, Pages

  Tesse, Angela ^a   Meziani, Ferhat ^a,b,d   David, Eric ^b   Carusio, Nunzia ^a   Kremer, Helene ^a   Schneider, Francis ^b   Andriantsitohaina, Ramaroson ^a,c  

^a CNRS   (France)

^b HÔPITAL DE HAUTEPIERRE   (France)

^c INSERM   (France)

^d ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

Nitric oxide; Preeclampsia; Pregnancy; Prostaglandin

Indexed keywords

8 ISOPROSTANE; CYCLOOXYGENASE 2; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PROSTAGLANDIN E2; SEROTONIN; THROMBOXANE B2;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL REACTIVITY; CIRCULATION; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; HUMAN; MOUSE; NONHUMAN; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN FUNCTION; VASCULAR RING; VASOCONSTRICTION;

ANIMALS; AORTA; BIOLOGICAL FACTORS; FEMALE; HUMANS; MICE; MICE, INBRED C57BL; MICROSPHERES; NITRIC OXIDE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY, ANIMAL; VASCULAR DISEASES;

EID: 34547103989     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01094.2006     Document Type: Article

References (35)

1. Barry OP, Kazanietz MG, Pratico D, FitzGerald GA. Arachidonic acid in platelet microparticles up-regulates cyclooxygenase-2-dependent prostaglandin formation via a protein kinase C/mitogen-activated protein kinase-dependent pathway. J Biol Chem 274: 7545-7556, 1999.
2. Barry OP, Pratico D, Lawson JA, FitzGerald GA. Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J Clin Invest 99: 2118-2127, 1997.
3. Bobadilla LR, Perez-Alvarez V, Bracho Valdes I, Lopez-Sanchez P. Effect of pregnancy on the roles of nitric oxide and prostaglandins in 5-hydroxytryptamine-induced contractions in rat isolated thoracic and abdominal aorta. Clin Exp Pharmacol Physiol 32: 202-209, 2005.
4. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 20: IX-XIV, 2001.
5. Clark BA, Halvorson L, Sachs B, Epstein FH. Plasma endothelin levels in preeclampsia: elevation and correlation with uric acid levels and renal impairment. Am J Obstet Gynecol 166: 962-968, 1992.
6. Cracowski JL. Isoprostanes: an emerging role in vascular physiology and disease? Chem Phys Lipids 128: 75-83, 2004.
7. 1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase. Circulation 107: 1632-1639, 2003.
8. Gluais P, Lonchampt M, Morrow JD, Vanhoutte PM, Feletou M. Acetylcholine-induced endothelium-dependent contractions in the SHR aorta: the Janus face of prostacyclin. Br J Pharmacol 146: 834-845, 2005.
9. Gonzalez-Quintero VH, Jimenez JJ, Jy W, Mauro LM, Hortman L, O'Sullivan MJ, Ahn Y. Elevated plasma endothelial microparticles in preeclampsia. Am J Obstet Gynecol 189: 589-593, 2003.
10. Habermehl DA, Janowiak MA, Vagnoni KE, Bird IM, Magness RR. Endothelial vasodilator production by uterine and systemic arteries. IV. Cyclooxygenase isoform expression during the ovarian cycle and pregnancy in sheep. Biol Reprod 62: 781-788, 2000.
11. Hubel CA. Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med 222: 222-235, 1999.
12. Hugel B, Zobairi F, Freyssinet JM. Measuring circulating cell-derived microparticles. J Thromb Haemost 2: 1846-1847, 2004.
13. Jonhson RD, Savodsky Y, Graham C, Anteby EY, Polakoski KL, Huang X, Nelson DM. The expression and activity of prostaglandin H synthase-2 is enhanced in trophoblast from women with preeclampsia. J Clin Endocrinol Metab 82: 3059-3062, 1997.
14. Khalil RA, Granger JP. Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models. Am J Physiol Regul Integr Comp Physiol 283: R29-R45, 2002.
15. Leik CE, Walsh SW. Neutrophils infiltrate resistance-sized vessels of subcutaneous fat in women with preeclampsia. Hypertension 44: 72-77, 2004.
16. Lowe DT. Nitric oxide dysfunction in the pathophysiology of preeclampsia. Nitric Oxide 4: 441-458, 2000.
17. Martinez MC, Tesse A, Zobairi F, Andriantsitohaina R. Shed membrane microparticles from circulating and vascular cells in regulating vascular function. Am J Physiol Heart Circ Physiol 288: H1004-H1009, 2005.
18. Meziani F, Tesse A, David E, Wangesteen R, Schneider F, Andriantsitohaina R. Shed membrane particles from preeclamptic women generate vascular wall inflammation and blunt vascular contractility. Am J Pathol 169: 1473-1483, 2006.
19. Mulsch A, Mordvintcev P, Bassenge E, Jung F, Clement B, Busse R. In vivo spin trapping of glyceryl trinitrate-derived nitric oxide in rabbit blood vessels and organs. Circulation 92: 1876-1882, 1995.
20. Nelson SH, Steinsland OS, Wang Y, Yallampalli C, Dong YL, Sanchez JM. Increased nitric oxide synthase activity and expression in the human uterine artery during pregnancy. Circ Res 87: 406-411, 2000.
21. Poston L, McCarthy AL, Ritter JM. Control of vascular resistance in the maternal and feto-placental arterial beds. Pharmacol Ther 65: 215-239, 1995.
22. 2α. J Biol Chem 270: 9800-9808, 1995.
23. Report of the National High Blood Pressure Education Program Working Group. Report on high blood pressure in pregnancy. Am J Obstet Gynecol 183 Suppl: S1-S22, 2002.
24. Roberts J. Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol 16: 5-15, 1998.
25. Roberts JM, Redman CWG. Preeclampsia: more than pregnancy-induced hypertension. Lancet 341: 1447-1451, 1993.
26. Salvemini D, Manning PT, Zweifel BS, Seibert K, Connor J, Currie MG, Needleman P, Masferrer JL. Dual inhibition of nitric oxide and prostaglandin production contributes to the anti-inflammatory properties of nitric oxide synthase inhibitors. J Clin Invest 96: 301-308, 1995.
27. Salvemini D, Misko TP, Masferrer JL, Seibert K, Currie MG, Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 90: 7240-7244, 1993.
28. Stoclet JC, Martinez MC, Ohlmann P, Chasserot S, Schott C, Kleschyov AL, Schneider F, Andriantsitohaina R. Induction of NO-synthase and dual effects of NO and cyclo-oxygenase products in regulation of arterial contraction in human septic shock. Circulation 100: 107, 1999.
29. Tesse A, Martinez MC, Hugel B, Chalupsky K, Muller CD, Meziani F, Mitolo-Chieppa D, Freyssinet JM, Andriantsitohaina R. Upregulation of proinflammatory proteins through NF-κB pathway by shed membrane microparticles results in vascular hyporeactivity. Arterioscler Thromb Vasc Biol 25: 2522-2527, 2005.
30. VanWijk MJ, Nieuwland R, Boer K, van der Post JA, VanBavel E, Sturk A. Microparticle subpopulations are increased in preeclampsia: possible involvement in vascular dysfunction? Am J Obstet Gynecol 187: 450-456, 2002.
31. VanWijk MJVE, Sturk A, Nieuwland R. Microparticles in cardiovascular diseases. Cardiovasc Res 59: 277-287, 2003.
32. VanWijk MJ, Svedas E, Boer K, Nieuwland R, VanBavel E, Kublickiene R. Isolated microparticles, but not whole plasma, from women with preeclampsia impair endothelium-dependent relaxation in isolated myometrial arteries from healthy pregnant women. Am J Obstet Gynecol 187: 1686-1693, 2002.
33. Walsh SW. Eicosanoids in preeclampsia. Prostaglandins Leukot Essent Fatty Acids 70: 223-232, 2004.
34. Walsh SW, Vaughan JE, Wang Y, Roberts LJ 2nd. Placental isoprostane is significantly increased in preeclampsia. FASEB J 14: 1289-1296, 2000.
35. Zwaal RF, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 89: 1121-1132, 1997.